92 related articles for article (PubMed ID: 15466898)
1. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.
Lallemand F; Soubrié P; De Witte P
Alcohol Alcohol; 2004; 39(6):486-92. PubMed ID: 15466898
[TBL] [Abstract][Full Text] [Related]
2. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration.
Lallemand F; Soubrié PH; De Witte PH
Alcohol Clin Exp Res; 2001 Sep; 25(9):1317-23. PubMed ID: 11584151
[TBL] [Abstract][Full Text] [Related]
3. SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats.
Lallemand F; De Witte P
Alcohol; 2006 Jul; 39(3):125-34. PubMed ID: 17127132
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
[TBL] [Abstract][Full Text] [Related]
6. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
Pavon FJ; Bilbao A; Hernández-Folgado L; Cippitelli A; Jagerovic N; Abellán G; Rodríguez-Franco MA; Serrano A; Macias M; Gómez R; Navarro M; Goya P; Rodríguez de Fonseca F
Neuropharmacology; 2006 Aug; 51(2):358-66. PubMed ID: 16750544
[TBL] [Abstract][Full Text] [Related]
7. Effects of SR141716A on ethanol and sucrose self-administration.
Freedland CS; Sharpe AL; Samson HH; Porrino LJ
Alcohol Clin Exp Res; 2001 Feb; 25(2):277-82. PubMed ID: 11236843
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.
Rubino T; Patrini G; Massi P; Fuzio D; Viganò D; Giagnoni G; Parolaro D
J Pharmacol Exp Ther; 1998 May; 285(2):813-9. PubMed ID: 9580631
[TBL] [Abstract][Full Text] [Related]
9. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats.
Gessa GL; Serra S; Vacca G; Carai MA; Colombo G
Alcohol Alcohol; 2005; 40(1):46-53. PubMed ID: 15582988
[TBL] [Abstract][Full Text] [Related]
10. Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats.
Morales M; McGinnis MM; McCool BA
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):67-76. PubMed ID: 26515190
[TBL] [Abstract][Full Text] [Related]
11. Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats.
Serra S; Brunetti G; Pani M; Vacca G; Carai MA; Gessa GL; Colombo G
Eur J Pharmacol; 2002 May; 443(1-3):95-7. PubMed ID: 12044797
[TBL] [Abstract][Full Text] [Related]
12. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol.
Economidou D; Mattioli L; Ubaldi M; Lourdusamy A; Soverchia L; Hardiman G; Campolongo P; Cuomo V; Ciccocioppo R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):73-85. PubMed ID: 17618662
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome.
Rubino T; Massi P; Viganò D; Fuzio D; Parolaro D
Life Sci; 2000 Apr; 66(22):2213-9. PubMed ID: 10834304
[TBL] [Abstract][Full Text] [Related]
15. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.
Wang L; Liu J; Harvey-White J; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1393-8. PubMed ID: 12538878
[TBL] [Abstract][Full Text] [Related]
17. Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model.
Robinson SL; McCool BA
Physiol Behav; 2015 Oct; 149():119-30. PubMed ID: 26037631
[TBL] [Abstract][Full Text] [Related]
18. Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference.
Lallemand F; de Witte P
Alcohol Alcohol; 2005; 40(1):54-62. PubMed ID: 15550449
[TBL] [Abstract][Full Text] [Related]
19. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
López-Moreno JA; González-Cuevas G; Navarro M
Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
